tirzepatide dangers FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Criminals selling dangerous weight-loss jabs
Description
"That night was harrowing," Mollen said
Myth #9: It Stops Working After 3-4 Months The Claim: Everyone hits a plateau at month 3 and stops losing weight completely, the medication stops working (YouTube comment) The Reality: Weight loss continues through 48 weeks in clinical trials, though rate of loss slows over time
The study also shows that markers of neuronal cell stress and apoptosis, namely metalloproteinase-3, were significantly reduced upon the administration of GLP-1 [70]
This timing aligns with the medication's mechanism: semaglutide activates GLP-1 receptors in your brainstem and gut, slowing gastric emptying and enhancing satiety signals almost immediately
A generic version would require those patents to expire or be successfully challenged, plus a separate FDA approval process for the generic
